Acute coronary syndrome in COVID-19 patients. Clinical features, severity and outcomes. Results from Spanish multicenter registry Car-COVID19
| Autor: | E Barge Caballero, M Sanmartin Fernandez, A Garcia Del Egido, M Corbi Pascual, L Martinez Dolz, M Anguita Sanchez, P Jorge Perez, JM Escudier Villa, J Cosin Sales, S Raposeiras Roubin, G Baron Esquivas, M Abellas Sequeiros, C Gonzalez Juanatey, J L Zamorano, VM Becerra Munoz |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Acute aortic syndrome
medicine.medical_specialty Acute coronary syndrome Aspirin business.industry medicine.medical_treatment Percutaneous coronary intervention General Medicine 18.2 - Epidemiology Prognosis Outcome Critical Care and Intensive Care Medicine medicine.disease Coronary artery bypass surgery AcademicSubjects/MED00170 Diabetes mellitus Internal medicine medicine Extracorporeal membrane oxygenation AcademicSubjects/MED00200 Myocardial infarction Cardiology and Cardiovascular Medicine business AcademicSubjects/MED00460 medicine.drug |
| Zdroj: | European Heart Journal. Acute Cardiovascular Care |
| ISSN: | 2048-8734 2048-8726 |
| Popis: | Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): Fundación del Corazón Introduction COVID19 has spread uncontrollably all over the world through this 2020 year. As a new entity, we did not know the potential cardiovascular manifestations of this infectious disease. This national registry was created to describe the cardiac affection and its severity. Methods and results A multicenter registry was conducted, including 28 centers in Spain. Patients with COVID19 diagnosis presenting an acute cardiovascular event between March 1st and May 30th were included. Eighty-two patients were included. Of them, 49 (76,6%) presented with acute coronary syndrome; the rest were diagnosed of acute myocarditis or stress cardiomyopathy. The majority of cases were STEMI (n = 31), while the remaining 35,4% presented as NSTEMI. 29 patients (61,7%) underwent emergent percutaneous coronary intervention (PCI) (Figure 1). Anterior (n = 18) and inferior (n = 16) were the most frequent locations. Coronary angiogram showed total occlusion in 20 patients (55,6%); while 7 patients presented with non-obstructive coronary arteries. PCI was done in 31 patients. Eight patients (17,8%) developed Killip III-IV myocardial infarction. A total of 10 patients required endotracheal intubation and vasoactive agent were needed in 11 patients; none required IABP or ECMO. In-hospital mortality rate was 26,2%. Conclusions Patients with COVID19 may present with acute coronary syndromes. This entity has a poor prognosis, with noteworthy mortality. Table 1. Baseline characteristics.n (%)Age69,0[63,0-76,5]Sex (female)9 (19,1%)Hypertension28 (57,1%)Dyslipidemia25 (51,0%)Diabetes mellitus11 (22,4%)Chronic coronary disease10 (20,4%)Previous PCI10 (20,4%)Previous CABG0Previous AAS15 (30,6%)Smoking10 (20,4%)PCI percutaneous coronary intervention; CABG: coronary artery bypass graft; AAS: aspirin.Abstract Figure 1. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|